Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines

Panov, Alexander V., Gutekunst, Claire-Anne, Leavitt, Blair R., Hayden, Michael R., Burke, James R., Strittmatter, Warren J., Greenamyre, J. Timothy·2002·Nature Neuroscience

DOI 10.1038/nn884

Cited by (1,000)

Items 301–400 of 1,000

The role of oxidative stress in Huntington’s disease: Are antioxidants good therapeutic candidates?
Gil-Mohapel, Joana, Brocardo, Patricia, Christie, Brian · 2014 · Current Drug Targets
Mitochondrial dysfunction, metabolic deficits, and increased oxidative stress in Huntington's disease.
Chiung‐Mei Chen · 2011 · PubMed
Mitochondrial Dysfunction in Skeletal Muscle Pathologies
Abrigo, Johanna, Simon, Felipe, Cabrera, Daniel, Vilos, Cristian, Cabello-Verrugio, Claudio · 2019 · Current Protein & Peptide Science
Impaired Regulation of Brain Mitochondria by Extramitochondrial Ca2+ in Transgenic Huntington Disease Rats
Frank Norbert Gellerich, Zemfira Z. Gizatullina, Huu Phuc Nguyen, Sonata Trumbeckaitė, Stefan Vielhaber, Enn K. Seppet, Stephan Zierz, G. Bernhard Landwehrmeyer, Olaf Rieß, Stephan von Hörsten et al. · 2008 · Journal of Biological Chemistry
Role of proteolysis in polyglutamine disorders
Volga Tarlac, Elsdon Storey · 2003 · Journal of Neuroscience Research
Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo?
Nadia Cummins, Jürgen Götz · 2017 · Cellular and Molecular Life Sciences
Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration
G.D. Zeevalk, Laura P. Bernard, Chunjuan Song, Matthew J. Gluck, Julie Ehrhart · 2005 · Antioxidants and Redox Signaling
Mitochondrial quality control and neurological disease: an emerging connection
Inês Pimenta de Castro, L. Miguel Martins, Roberta Tufi · 2010 · Expert Reviews in Molecular Medicine
Creatine therapy for Huntington’s disease: Clinical and MRS findings in a 1-year pilot study
Sarah J. Tabrizi, Andrew Matthew Blamire, David Neil Manners, B Rajagopalan, Peter Styles, Anthony H.V. Schapira, Thomas T. Warner · 2003 · Neurology
Role of intracellular calcium signaling in the pathophysiology and pharmacotherapy of bipolar disorder: current status
Jerry J. Warsh, Stavroula Andreopoulos, Peter P. Li · 2004 · Clinical Neuroscience Research
Calcium-dependent Cleavage of Endogenous Wild-type Huntingtin in Primary Cortical Neurons
Donato Goffredo, Dorotea Rigamonti, Marzia Tartari, Alberto De Micheli, Claudia Verderio, Michela Matteoli, Chiara Zuccato, Elena F. Cattaneo · 2002 · Journal of Biological Chemistry
EXPRESSION OF CONCERN: Ginsenosides protect striatal neurons in a cellular model of Huntington's disease
Jun Wu, Hye Kyoung Jeong, Sarah E. Bulin, Sung Won Kwon, Jeong Hill Park, Безпрозванный Илья Борисович · 2009 · Journal of Neuroscience Research
Mitochondrial quality control: The role of mitophagy in aging
Ruo‐Yang Shi, Matthew Guberman, Lorrie A. Kirshenbaum · 2017 · Trends in Cardiovascular Medicine
Calcium Signaling and Neurodegeneration
Безпрозванный Илья Борисович · 2010 · Acta Naturae
Mitochondria and Energetic Depression in Cell Pathophysiology
Enn K. Seppet, Marju Puurand, Ants Peetsalu, Zemfira Z. Gizatullina, Huu Phuc Nguyen, Stefan Vielhaber, Manfred H.P. Wussling, Sonata Trumbeckaitė, Odeta Arandarčikaitė, Doreen Jerzembek et al. · 2009 · International Journal of Molecular Sciences
Effects of CAG repeat length, HTT protein length and protein context on cerebral metabolism measured using magnetic resonance spectroscopy in transgenic mouse models of Huntington's disease
Bruce G. Jenkins, Ole A. Andreassen, Alpaslan Dedeoglu, Blair R. Leavitt, Michael R. Hayden, David Borchelt, Christopher A. Ross, Robert J. Ferrante, M. Flint Beal · 2005 · Journal of Neurochemistry
Cellular and subcellular localization of Huntington aggregates in the brain of a rat transgenic for Huntington disease
Elisabeth Petrasch‐Parwez, Huu Phuc Nguyen, Marlen Löbbecke‐Schumacher, Hans‐Werner Habbes, Stefan Wieczorek, Olaf Rieß, Karl Hermann Andres, Rolf Dermietzel, Stephan von Hörsten · 2007 · The Journal of Comparative Neurology
Autophagy of Mitochondria: A Promising Therapeutic Target for Neurodegenerative Disease
Pradip Kumar Kamat, Anuradha Kalani, Philip Kyles, Suresh C. Tyagi, Neetu Tyagi · 2014 · Cell Biochemistry and Biophysics
Treating neurodegeneration by modifying mitochondria: potential solutions to a “complex” problem
Swerdlow, Russell H. · 2007 · Antioxidants & Redox Signaling
Enhanced Ca2+-dependent glutamate release from astrocytes of the BACHD Huntington's disease mouse model
William Lee, Reno C. Reyes, Manoj K. Gottipati, Karon C. Lewis, Mathieu J. Lesort, Vladimir Parpura, Michelle Gray · 2013 · Neurobiology of Disease
The Mitochondrial Calcium Uniporter (MCU): Molecular Identity and Role in Human Diseases
Donato D’Angelo, Rosario Rizzuto · 2023 · Biomolecules
Cell Death Pathways in Parkinson's Disease: Role of Mitochondria
Zhi Yao, Nicholas William Wood · 2009 · Antioxidants and Redox Signaling
Neuroprotective Effects of Synaptic Modulation in Huntington's Disease R6/2 Mice
Edward C. Stack, Alpaslan Dedeoglu, Karen M. Smith, Kerry Cormier, James K. Kubilus, Mikhail B. Bogdanov, Wayne R. Matson, Lichuan Yang, Bruce G. Jenkins, Ruth Luthi‐Carter et al. · 2007 · Journal of Neuroscience
The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease
Youngnam N. Jin, Gail V.W. Johnson · 2010 · Journal of Bioenergetics and Biomembranes
Implications of mitochondrial dynamics on neurodegeneration and on hypothalamic dysfunction
Antonio Zorzano A, Marc Claret · 2015 · Frontiers in Aging Neuroscience
Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington’s Disease Human Lymphoblasts
Luana Naia, Ildete L. Ferreira, Teresa Cunha‐Oliveira, Ana Isabel Duarte, Márcio Ribeiro, Tatiana Rosado Rosenstock, Mário Laço, Maria J. Ribeiro, Catarina Resende Oliveira, Frédéric Saudou et al. · 2014 · Molecular Neurobiology
Animal models of bipolar disorder
Tadafumi Kato, Mie Kubota, Takaoki Kasahara · 2007 · Neuroscience & Biobehavioral Reviews
Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Associates with Huntingtin Protein and Promotes Its Atypical Ubiquitination to Enhance Aggregate Formation
Silvia Zucchelli, Federica Marcuzzi, Marta Codrich, Elena Agostoni, Sandra Vilotti, Marta Biagioli, Milena Pinto, Alisia Carnemolla, Claudio Santoro, Stefano Gustincich et al. · 2011 · Journal of Biological Chemistry
Coenzyme Q treatment of neurodegenerative diseases of aging
Wendy R. Galpern, Merit Cudkowicz · 2007 · Mitochondrion
Adenosine Monophosphate–Activated Kinase and Its Key Role in Catabolism: Structure, Regulation, Biological Activity, and Pharmacological Activation
Sukriti Krishan, Des Raymond Richardson, Sumit Sahni · 2014 · Molecular Pharmacology
Striatal Vulnerability in Huntington’s Disease: Neuroprotection Versus Neurotoxicity
Ryoma Morigaki, Satoshi Goto · 2017 · Brain Sciences
Influence of cytosolic and mitochondrial Ca2+, ATP, mitochondrial membrane potential, and calpain activity on the mechanism of neuron death induced by 3-nitropropionic acid
Payman Nasr, H. Gursahani, Zhen Pang, Vimala Bondada, Jaewon Lee, Robert W. Hadley, James W. Geddes · 2003 · Neurochemistry International
Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration
Laura Danielle Osellame, Michael R. Duchen · 2013 · British Journal of Pharmacology
Mitochondrial Ca 2+ sequestration and precipitation revisited
Christos Chinopoulos, Vera Ádám‐Vizi · 2010 · FEBS Journal
Mitochondrial dysfunction in human pathologies
Marı́a Monsalve · 2006 · Frontiers in bioscience
Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease
Nicholas S. Caron, Amber L. Southwell, Cynthia C. Brouwers, Louisa Dal Cengio, Yuanyun Xie, Hailey Findlay Black, Lisa M. Anderson, Seunghyun Ko, Xiang Zhu, Sander J. H. van Deventer et al. · 2019 · Nucleic Acids Research
Mitochondrial Abnormalities and Synaptic Damage in Huntington’s Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics
Neha A. Sawant, Hallie Morton, Sudhir Kshirsagar, Arubala P. Reddy, P. Hemachandra Reddy · 2021 · Molecular Neurobiology
Unbiased Gene Expression Analysis Implicates the huntingtin Polyglutamine Tract in Extra-mitochondrial Energy Metabolism
Lee, Jong-Min, Ivanova, Elena V, Seong, Ihn Sik, Cashorali, Tanya, Kohane, Isaac, Gusella, James F, MacDonald, Marcy E · 2007 · PLoS Genetics
Development of Therapeutics That Induce Mitochondrial Biogenesis for the Treatment of Acute and Chronic Degenerative Diseases
Robert Bruce Cameron, Craig Beeson, Rick G. Schnellmann · 2016 · Journal of Medicinal Chemistry
Cystamine and cysteamine prevent 3‐NP‐induced mitochondrial depolarization of Huntington's disease knock‐in striatal cells
Zhengkuan Mao, Yeun Su Choo, Mathieu J. Lesort · 2006 · European Journal of Neuroscience
Protective effects of ginseng saponins on 3-nitropropionic acid-induced striatal degeneration in rats
Jong‐Hoon Kim, Sunoh Kim, In‐Soo Yoon, Jong-Hwan Lee, Byung-Jun Jang, Sang Min Jeong, Jun‐Ho Lee, Byung-Hwan Lee, Jin-Soo Han, Sekwan Oh et al. · 2005 · Neuropharmacology
Low stability of huntington muscle Mitochondria against Ca2+ in R6/2 mice
Zemfira Z. Gizatullina, Katrin S. Lindenberg, Phoebe Harjes, Ying Chen, Christoph Michael Kosinski, G. Bernhard Landwehrmeyer, Albert C. Ludolph, Frank Striggow, Stephan Zierz, Frank Norbert Gellerich · 2006 · Annals of Neurology
Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington's disease
Eleonora Napoli, Sarah Wong, Connie Hung, Catherine Ross‐Inta, Prithvi R. Bomdica, Cecilia Giulivi · 2012 · Human Molecular Genetics
Dopamine determines the vulnerability of striatal neurons to the N-terminal fragment of mutant huntingtin through the regulation of mitochondrial complex II
Alexandra Benchoua, Yaël Trioulier, Elsa Diguet, Carole Malgorn, Marie‐Claude Gaillard, Noëlle Dufour, Jean‐Marc Elalouf, Stan Krajewski, Philippe Hantraye, Nicole Déglon et al. · 2008 · Human Molecular Genetics
Huntingtin inclusion bodies are iron‐dependent centers of oxidative events
Firdaus, Wance J. J., Wyttenbach, Andreas, Giuliano, Paola, Kretz‐Remy, Carole, Currie, R. William, Arrigo, André‐Patrick · 2006 · The FEBS Journal
Mitochondrial dysfunction in psychiatric and neurological diseases: Cause(s), consequence(s), and implications of antioxidant therapy
Deepak Mahadev Kasote, Mahabaleshwar Vishnu Hegde, Surendra S. Katyare · 2013 · BioFactors
Abnormal morphology of peripheral cell tissues from patients with Huntington disease
Ferdinando Squitieri, Alessandra Falleni, Milena Cannella, Sara Orobello, Federica Fulceri, Paola Lenzi, Francesco Fornai · 2009 · Journal of Neural Transmission
Impaired mitochondrial trafficking in Huntington's disease
Xiao‐Jiang Li, Adam L. Orr, Shihua Li · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Bi-phasic dose response in the preclinical and clinical developments of sigma-1 receptor ligands for the treatment of neurodegenerative disorders
Tangui Maurice · 2020 · Expert Opinion on Drug Discovery
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
Raut, Snehal, Bhalerao, Aditya, Powers, Michael, Gonzalez, Minelly, Mancuso, Salvatore, Cucullo, Luca · 2023 · Cells
Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington's disease
Wang, Yiqin, Guo, Xiaoxian, Ye, Kaixiong, Orth, Michael, Gu, Zhenglong · 2021 · Proceedings of the National Academy of Sciences
Isolation of Mitochondria from the CNS
Tibor Kristián · 2010 · Current Protocols in Neuroscience
AMPK-mediated regulation of neuronal metabolism and function in brain diseases
Yu‐Ju Liu, Yijuang Chern · 2015 · Journal of Neurogenetics
The therapeutic role of creatine in Huntington's disease
Hoon Ryu, Herminia Diana Rosas, Steven M. Hersch, Robert J. Ferrante · 2005 · Pharmacology & Therapeutics
Juvenile Huntington's disease: Does a dosage-effect pathogenic mechanism differ from the classical adult disease?
Ferdinando Squitieri, Luigi Frati, Andrea Ciarmiello, Secondo Lastoria, Oliver W J Quarrell · 2005 · Mechanisms of Ageing and Development
From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease
Jonasz Jeremiasz Weber, Anna Sergeevna Sowa, Tina Binder, Jeannette Hübener‐Schmid · 2014 · BioMed Research International
Mitochondrial toxins and neurodegenerative diseases
Antonio Ayala · 2006 · Frontiers in bioscience
Adenosine and glutamate extracellular concentrations and mitogen-activated protein kinases in the striatum of Huntington transgenic mice. Selective antagonism of adenosine A2A receptors reduces transmitter outflow
Marco Gianfriddo, Alessia Melani, D. Turchi, Maria Grazia Giovannini, Felicita Pedata · 2004 · Neurobiology of Disease
The paradigm of Huntington’s disease: Therapeutic opportunities in neurodegeneration
Julie Leegwater‐Kim, Jang-Ho J. Cha · 2004 · NeuroRx
Transducer of regulated CREB-binding proteins (TORCs) transcription and function is impaired in Huntington's disease
Rajnish Kumar Chaturvedi, Thomas Hennessey, Ashu Johri, Shashi Kant Tiwari, Divya Mishra, Swati Agarwal, Yoon Seong Kim, M. Flint Beal · 2012 · Human Molecular Genetics
Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review
Musthafa Mohamed Essa, Marzieh Moghadas, Taher Ba-Omar, M. Walid Qoronfleh, Gilles J. Guillemin, Thamilarasan Manivasagam, Arokiasamy Justin‐Thenmozhi, Bipul Ray, Abid Bhat, Saravana Babu Chidambaram et al. · 2019 · Neurotoxicity Research
Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3‐nitropropionic acid‐induced striatal damage
J. Stephen Fink, Anti Kalda, Hoon Ryu, Edward C. Stack, Michael A. Schwarzschild, Jiang‐Fan Chen, Robert J. Ferrante · 2003 · Journal of Neurochemistry
Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines
Dénes Zádori, Péter Klivènyi, Imola Plangár, József Toldi, László Vécsei · 2010 · Journal of Cellular and Molecular Medicine
Glutathione redox cycle dysregulation in Huntington’s disease knock-in striatal cells
Márcio Ribeiro, Tatiana Rosado Rosenstock, Teresa Cunha‐Oliveira, Ildete L. Ferreira, Catarina Resende Oliveira, Ana Cristina Rego · 2012 · Free Radical Biology and Medicine
Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington’s disease
Wang‐Tso Lee, Chen Chang · 2004 · Progress in Neurobiology
The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models
Luana Naia, P. Ly, S. Mota, Carla Lopes, Carina Maranga, Patrícia Coelho, Noga Gershoni-Emek, M. Ankarcrona, M. Geva, M. Hayden et al. · 2021 · Neurotherapeutics
Elucidating the role of the A2Aadenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs
Feng‐Lan Chiu, Jun-Tasi Lin, Ching-Yu Chuang, Ting Chien, Chiung‐Mei Chen, Kai-Hsiang Stanley Chen, Han‐Yun Hsiao, Yow‐Sien Lin, Yijuang Chern, Hung‐Chih Kuo · 2015 · Human Molecular Genetics
Metabolic Stress and Disorders Related to Alterations in Mitochondrial Fission or Fusion.
Mansi Babbar, M. Saeed Sheikh · 2013 · PubMed
Calcium-mediated cellular signals: a story of failures
Ernesto Carafoli · 2004 · Trends in Biochemical Sciences
Energy defects in Huntington's disease: Why “in vivo” evidence matters
Géraldine Liot, Julien Valette, Jérémy Pépin, Julien Flament, Emmanuel Brouillet · 2016 · Biochemical and Biophysical Research Communications
Mitochondrial Permeability Transition, Cell Death and Neurodegeneration
Artyom Y. Baev, Andrey Yurievich Vinokurov, Elena Potapova, Andrey Dunaev, Plamena R. Angelova, Andrey Y. Abramov · 2024 · Cells
Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference
Zongyu J. Chen, Betsy T. Kren, Phillip Y.-P. Wong, Walter C. Low, Clifford J. Steer · 2005 · Biochemical and Biophysical Research Communications
TGM2 and implications for human disease: role of alternative splicing
Charles S. Greenberg · 2012 · Frontiers in bioscience
Mitochondrial Importance in Alzheimer’s, Huntington’s and Parkinson’s Diseases
Sónia C. Correia, Renato X. Santos, George L. Perry, Xiongwei Zhu, Paula Isabel Moreira, Mark A. Smith · 2012 · Advances in experimental medicine and biology
Neuroprotection by Radical Avoidance: Search for Suitable Agents
Rüdiger Hardeland · 2009 · Molecules
SUMO peptidase ULP-4 regulates mitochondrial UPR-mediated innate immunity and lifespan extension
Kaiyu Gao, Yi Li, Shumei Hu, Ying Liu · 2019 · eLife
Brain mitochondrial defects amplify intracellular [Ca2+] rise and neurodegeneration but not Ca2+entry during NMDA receptor activation
Carine Jacquard, Yaël Trioulier, François Cosker, Carole Escartin, Nicolas Bizat, Philippe Hantraye, José‐Manuel Cancela, Gilles Bonvento, Emmanuel Brouillet · 2006 · The FASEB Journal
Ethyl-EPA treatment improves motor dysfunction, but not neurodegeneration in the YAC128 mouse model of Huntington disease
Jeremy M. Van Raamsdonk, Jacqueline Pearson, Daniel A. Rogers, Ge Lu, Vilte Barakauskas, Alasdair M. Barr, William G. Honer, Michael R. Hayden, Blair R. Leavitt · 2005 · Experimental Neurology
Oxidative Stress in Skin Fibroblasts Cultures of Patients with Huntington’s Disease
Pilar del Hoyo, Alberto García‐Redondo, Fernando Bustos, José Antonio Molina, Youssef Sayed, Hortensia Alonso‐Navarro, Luis Caballero, Joaquı́n Arenas, Félix Javier Jiménez‐Jiménez · 2006 · Neurochemical Research
Hyperactive intracellular calcium dynamics in B lymphoblasts from patients with bipolar I disorder
Tatiana Perova, Michael J Wasserman, Peter P. Li, Jerry J. Warsh · 2007 · The International Journal of Neuropsychopharmacology
A single-chain Fv intrabody provides functional protection against the effects of mutant protein in an organotypic slice culture model of Huntington's disease
Robert C. Murphy, Anne C. Messer · 2004 · Molecular Brain Research
A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
Pawel Michal Switonski, Wojciech J. Szlachcic, Włodzimierz J. Krzyżosiak, Maciej Figiel · 2014 · Neurobiology of Disease
Huntington’s Disease: From Mutant Huntingtin Protein to Neurotrophic Factor Therapy
Youssef Sari · 2011 · International Journal of Biomedical Science
Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease
Péter Klivènyi, Robert J. Ferrante, Gabrielle Gardian, Susan E. Browne, Pierre‐Etienne Chabrier, M. Flint Beal · 2003 · Journal of Neurochemistry
CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons
Gong‐Her Wu, Charlene Smith-Geater, Jesús G. Galaz-Montoya, Yingli Gu, Sanket Rajan Gupte, Ranen Aviner, Patrick Mitchell, Joy Hsu, Ricardo Miramontes, Keona Q. Wang et al. · 2023 · Nature Communications
3‐Nitropropionic acid induces autophagy by forming mitochondrial permeability transition pores rather than activatiing the mitochondrial fission pathway
María E. Solesio, Sara Sáez-Atiénzar, Joaquı́n Jordán, María Francisca Galindo · 2012 · British Journal of Pharmacology
Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington’s disease patients
Sandra Almeida, Ana Bela Sarmento‐Ribeiro, Cristina Januário, Ana Cristina Rego, Catarina Resende Oliveira · 2008 · Biochemical and Biophysical Research Communications
Amyloid-Forming Proteins Alter the Local Mechanical Properties of Lipid Membranes
Kathleen A. Burke, Elizabeth A. Yates, Justin A. Legleiter · 2013 · Biochemistry
The role of mitochondrial dysfunction in Huntington’s disease: Implications for therapeutic targeting
Deepak Chandra Joshi, Mayuri Bapu Chavan, Kajal Gurow, Madhu Gupta, Jagjit Singh Dhaliwal, Long Chiau Ming · 2025 · Biomedicine & Pharmacotherapy
Gemini Surfactants Mediate Efficient Mitochondrial Gene Delivery and Expression
Ana Maria Cardoso, Catarina M. Morais, Ana Rita Cruz, Ana Luísa Cardoso, Sandra G. Silva, M.L.C. Vale, Eduardo Figueira Marques, Maria C. Pedroso de Lima, Amália S. Jurado · 2015 · Molecular Pharmaceutics
Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Levente Szalárdy, Péter Klivènyi, Dénes Zádori, Ferenc Fülöp, József Toldi, László Vécsei · 2012 · Current Medicinal Chemistry
Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease
Larissa Arning, Aiden Haghikia, Elahe Taherzadeh-Fard, Carsten Saft C, Jürgen Andrich, Bartosz Puła, Stefan Höxtermann, Stefan Wieczorek, Denis A. Akkad, Moritz Perrech et al. · 2010 · Journal of Molecular Medicine
Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria
Alexander V. Panov, Larisa V. Andreeva, J. Timothy Greenamyre · 2004 · Archives of Biochemistry and Biophysics
The use of transgenic and knock-in mice to study Huntington’s disease
Miriam Ann Hickey, M.-F. Chesselet · 2003 · Cytogenetic and Genome Research
Bioenergetic dysfunction in Huntington's disease human cybrids
Ildete L. Ferreira, Teresa Cunha‐Oliveira, Maria V. Nascimento, Márcio Ribeiro, M. Teresa Proença, Cristina Januário, Catarina Resende Oliveira, Ana Cristina Rego · 2011 · Experimental Neurology
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo
Isabel Lastres‐Becker, Nicolas Bizat, Frédéric Boyer, Philippe Hantraye, Javier Fernández‐Ruíz, Emmanuel Brouillet · 2004 · Neuroreport
GENE–ENVIRONMENT INTERACTIONS, NEURONAL DYSFUNCTION AND PATHOLOGICAL PLASTICITY IN HUNTINGTON'S DISEASE
Anton van Dellen, Helen Grote, Anthony John Hannan · 2005 · Clinical and Experimental Pharmacology and Physiology
The 3‐NP Model of Striatal Neurodegeneration
Emmanuel Brouillet · 2014 · Current Protocols in Neuroscience
Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington’s disease
Soon‐Tae Lee, Kon Chu, Jung‐Eun Park, Lami Kang, Song‐Yi Ko, Keun‐Hwa Jung, Manho Kim · 2006 · Brain Research
HAP1 facilitates effects of mutant huntingtin on inositol 1,4,5‐trisphosphate‐induced Ca2+ release in primary culture of striatal medium spiny neurons
Tie‐Shan Tang, Huiping Tu, Paul C. Orban, Edmond Y. W. Chan, Michael R. Hayden, Безпрозванный Илья Борисович · 2004 · European Journal of Neuroscience